Profits soar at Puleva

Related tags Nutrition

Puleva Biotech, the R&D subsidiary of Spanish food group Ebro
Puleva, reported a 57 per cent rise in profits over 2003 to €1.9

Net turnover grew 26 per cent to €4.6 million.

The company said growth was driven by provision of its R&D services to outside companies.

Puleva Biotech, which is hoping to sign marketing agreements with multinationals for some of its functional food developments this year, also implemented a number of new technologies last year, including molecular evolution techniques for the production of proteins, a genomic reasearch platform to study the effects of different nutrients and foods on the expression of certain genes and a metabolic unit to assess the effects of functional foods on humans.

A report by Spanish paper La Gaceta​ last year said the firm is ready to start production of a novel fat, to be used in foods made by its parent company, that could help reduce heart disease risk.

Related topics Suppliers Probiotics and prebiotics

Related news

Related products

show more

Prebiocran™, the new gut health solution

Prebiocran™, the new gut health solution

Content provided by Diana Food | 24-May-2023 | Research Study

Symrise is launching Prebiocran™, a 100% cranberry extract in powder designed to fit most of dietary supplement applications thanks to a low dosage: only...

Metabolic Health Starts in the Gut Microbiome

Metabolic Health Starts in the Gut Microbiome

Content provided by ADM | 10-May-2023 | White Paper

Emerging clinical evidence suggests that BPL1™ Probiotic and BPL1™ Postbiotic may effectively support aspects of metabolic health.

Skin microbiome: a research guide

Skin microbiome: a research guide

Content provided by Atlantia Clinical Trials | 04-Apr-2023 | White Paper

Validating claims is very important and there is an array of options available.

Related suppliers

Follow us


View more